| Pharmaceutical active ingredients: |
| Piroxicam |
| Available forms, composition and doses of Pyrocaps: |
| N / A |
| Pyrocaps medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AC01 - PiroxicamM02AA07 - PiroxicamS01BC06 - Piroxicam |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Be-Tabs Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Pyro | Alcohol | Unidentified Pharmaceutical Company |
| Pyroace | Pyrrolnitrin | Unidentified Pharmaceutical Company |
| Pyrobenzol | Benzene | Unidentified Pharmaceutical Company |
| Pyrobenzole | Benzene | Unidentified Pharmaceutical Company |
| Pyrocal | Cysteine; Haematoporphyrin | Dr. Mulli Pharma |
| Pyrocat | Dipyrocetyl | Unidentified Pharmaceutical Company |
| Pyrocellulose | Cellulose | Unidentified Pharmaceutical Company |
| Pyrochol | Desoxycholic Acid | Unidentified Pharmaceutical Company |
| Pyrocide | Pyrethrum | Unidentified Pharmaceutical Company |
| Pyrod | Uracil | Unidentified Pharmaceutical Company |